Category Investment

IMPACTS OF NEARSHORING ON DEMAND FOR MEXICAN LOGISTICS REAL ESTATE

INTRODUCTION In an increasingly volatile world, global companies are making decisions and investments to build resilience and flexibility. One key strategy is moving production closer to end consumers—nearshoring production—and in Northern America, we see Mexico benefiting significantly. This Prologis Research…

Read MoreIMPACTS OF NEARSHORING ON DEMAND FOR MEXICAN LOGISTICS REAL ESTATE

Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program

Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.85 per share from the current $0.775 per share, beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors…

Read MoreMorgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program

Macquarie Infrastructure Partners III announces agreement to divest Ceres Terminals

Macquarie Infrastructure Partners III (“MIP III”), an unlisted infrastructure fund managed by Macquarie Asset Management, announced that an agreement has been reached with Carrix, a leading marine terminal operator in the U.S. and the Americas, to divest MIP III’s ownership…

Read MoreMacquarie Infrastructure Partners III announces agreement to divest Ceres Terminals

Prosus delivers against strategic objectives and is on-track to achieve profitability target

In the second half of the year the Group made significant progress delivering on its strategic priorities, positioning it well for long-term value creation. The ongoing open-ended repurchase programme is creating significant value for shareholders and actions taken in H2…

Read MoreProsus delivers against strategic objectives and is on-track to achieve profitability target

Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), and Blackstone (NYSE: BX), today announced the companies have entered into a royalty financing collaboration agreement where funds managed by Blackstone Life Sciences…

Read MoreSutro Biopharma and Blackstone Announce Royalty Financing Collaboration